Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query

Bibliographic Details
Main Authors:	Khulood Al Kalbani, Anuradha Ganesh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Oman Journal of Ophthalmology
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2023;volume=16;issue=3;spage=397;epage=398;aulast=Al

Similar Items

Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2022-01-01)

Comparison of intravitreal injection of Ranibizumab versus Conbercept in the treatment of retinopathy of prematurity
by: Chen Juan, et al.
Published: (2024-05-01)

Effects of Ranibizumab on ocular biological parameters in the treatment of retinopathy of prematurity
by: Pan-Pan Ma, et al.
Published: (2023-05-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center
by: Feng-Yue Wu, et al.
Published: (2023-01-01)

Comparison of intravitreal ranibizumab and diod laser photocoagulation treatment for retinopathy of prematurity; effects on axial lenght and refractive status
by: Yusuf Koçluk, et al.
Published: (2019-03-01)

Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography
by: Lei Wu, et al.
Published: (2023-11-01)

Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy
by: Ze-Yu Liang, et al.
Published: (2022-10-01)

The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
by: Jing Chen, et al.
Published: (2023-10-01)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
by: Neelam Pawar, et al.
Published: (2023-01-01)

Long-term peripheral retinal vascular behavior in retinopathy of prematurity patients treated with ranibizumab intravitreal injection as monotherapy using fluorescein angiography
by: Raghad Al Rasheed, et al.
Published: (2022-08-01)

Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity
by: Vipul Prajapati, et al.
Published: (2023-01-01)

Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
by: Niza Alva, et al.
Published: (2023-08-01)

Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01)

Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
by: Ghada Mahmoud Tawfik, et al.
Published: (2022-10-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Vascularization of intravitreal injection of Conbercept in the treatment of retinopathy of prematurity
by: Zheng Fu, et al.
Published: (2023-03-01)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01)

Intravitreal Conbercept or Ranibizumab for myopic choroidal neovascularization
by: Cai-Yun Zhang, et al.
Published: (2022-06-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
by: Siying Li, et al.
Published: (2022-12-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01)

The Effect of Treated Retinopathy of Prematurity in Premature Infants on Ocular Structural Outcomes
by: Z Nezamdoost, et al.
Published: (2023-03-01)

Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds
by: Diana Rafael, et al.
Published: (2023-05-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept and laser for retinopathy of prematurity
by: Chang, ET, et al.
Published: (2022)

Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity
by: Jing-Ke Cao, et al.
Published: (2023-04-01)

Intravitreal Ranibizumab injection combined with trabeculectomy and PRP for neovascular glaucoma
by: Sheng-Fu Yang, et al.
Published: (2018-12-01)

Intravitreal Aflibercept Therapy in Intravitreal Bevacizumab/Ranibizumab Treatment-resistant Exudative Age-related Macular Degeneration
by: Neslihan Sevimli, et al.
Published: (2023-09-01)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
by: Ching-Yen Huang, et al.
Published: (2022-11-01)

Dramatic response of iris and retinal neovascularisation following usage of intravitreal ranibizumab as pre-operative adjunct in vitrectomy for advanced proliferative diabetic retinopathy
by: Malisa A,, et al.
Published: (2011)

Intravitreal injection of ranibizumab (Lucentis) versus pan-retinal photocoagulation as a preoperative adjuvant before vitrectomy in management of proliferative diabetic retinopathy
by: Mohammed S Ahmed
Published: (2021-01-01)

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
by: Xuemei Liang, et al.
Published: (2022-09-01)

An animal experimental study on the intravitreal injection of ranibizumab as an adjunctice treatment in retinoblastoma
by: Abd Aziz, Nor Azimah
Published: (2015)

Acute inflammatory demyelinating polyneuropathy shortly after administration of intravitreal ranibizumab
by: A. Fuerte-Hortigón, et al.
Published: (2023-05-01)

Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
by: Zhongjing Lin, et al.
Published: (2019-01-01)

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)

Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Didem sahin, et al.
Published: (2015-12-01)

Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report
by: A. N. Kulikov, et al.
Published: (2021-10-01)